Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99


Handheld confocal laser endomicroscopic imaging utilizing tumor-specific fluorescent labeling to identify experimental glioma cells in vivo.

Martirosyan NL, Georges J, Kalani MY, Nakaji P, Spetzler RF, Feuerstein BG, Preul MC.

Surg Neurol Int. 2016 Dec 12;7(Suppl 40):S995-S1003. doi: 10.4103/2152-7806.195577. eCollection 2016.


The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.

Joy A, Kapoor M, Georges J, Butler L, Chang Y, Li C, Crouch A, Smirnov I, Nakada M, Hepler J, Marty M, Feuerstein BG.

J Neurooncol. 2016 Oct;130(1):43-52. Epub 2016 Jul 15.


Use of a conformational switching aptamer for rapid and specific ex vivo identification of central nervous system lymphoma in a xenograft model.

Georges JF, Liu X, Eschbacher J, Nichols J, Mooney MA, Joy A, Spetzler RF, Feuerstein BG, Preul MC, Anderson T, Yan H, Nakaji P.

PLoS One. 2015 Apr 15;10(4):e0123607. doi: 10.1371/journal.pone.0123607. eCollection 2015.


AKT pathway genes define 5 prognostic subgroups in glioblastoma.

Joy A, Ramesh A, Smirnov I, Reiser M, Misra A, Shapiro WR, Mills GB, Kim S, Feuerstein BG.

PLoS One. 2014 Jul 1;9(7):e100827. doi: 10.1371/journal.pone.0100827. eCollection 2014.


Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.

Petrás M, Lajtos T, Friedländer E, Klekner A, Pintye E, Feuerstein BG, Szöllosi J, Vereb G.

Neuro Oncol. 2013 Aug;15(8):1027-40. doi: 10.1093/neuonc/not046. Epub 2013 Apr 17.


Intraoperative fluorescent imaging of intracranial tumors: a review.

Behbahaninia M, Martirosyan NL, Georges J, Udovich JA, Kalani MY, Feuerstein BG, Nakaji P, Spetzler RF, Preul MC.

Clin Neurol Neurosurg. 2013 May;115(5):517-28. doi: 10.1016/j.clineuro.2013.02.019. Epub 2013 Mar 21. Review.


DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis.

von Bueren AO, Gerss J, Hagel C, Cai H, Remke M, Hasselblatt M, Feuerstein BG, Pernet S, Delattre O, Korshunov A, Rutkowski S, Pfister SM, Baudis M.

J Neurooncol. 2012 Sep;109(2):415-23. doi: 10.1007/s11060-012-0911-7. Epub 2012 Jul 7.


Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.

Hu LS, Eschbacher JM, Heiserman JE, Dueck AC, Shapiro WR, Liu S, Karis JP, Smith KA, Coons SW, Nakaji P, Spetzler RF, Feuerstein BG, Debbins J, Baxter LC.

Neuro Oncol. 2012 Jul;14(7):919-30. doi: 10.1093/neuonc/nos112. Epub 2012 May 3.


Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.

Hu LS, Eschbacher JM, Dueck AC, Heiserman JE, Liu S, Karis JP, Smith KA, Shapiro WR, Pinnaduwage DS, Coons SW, Nakaji P, Debbins J, Feuerstein BG, Baxter LC.

AJNR Am J Neuroradiol. 2012 Jan;33(1):69-76. doi: 10.3174/ajnr.A2743. Epub 2011 Nov 17.


Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization.

Phillips JJ, Misra A, Feuerstein BG, Kunwar S, Tihan T.

Arch Pathol Lab Med. 2010 Jul;134(7):1063-9. doi: 10.1043/2009-0167-CR.1.


A multigene predictor of outcome in glioblastoma.

Colman H, Zhang L, Sulman EP, McDonald JM, Shooshtari NL, Rivera A, Popoff S, Nutt CL, Louis DN, Cairncross JG, Gilbert MR, Phillips HS, Mehta MP, Chakravarti A, Pelloski CE, Bhat K, Feuerstein BG, Jenkins RB, Aldape K.

Neuro Oncol. 2010 Jan;12(1):49-57. doi: 10.1093/neuonc/nop007. Epub 2009 Oct 20.


Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.

Hu LS, Baxter LC, Pinnaduwage DS, Paine TL, Karis JP, Feuerstein BG, Schmainda KM, Dueck AC, Debbins J, Smith KA, Nakaji P, Eschbacher JM, Coons SW, Heiserman JE.

AJNR Am J Neuroradiol. 2010 Jan;31(1):40-8. doi: 10.3174/ajnr.A1787. Epub 2009 Sep 12.


Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.

Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE.

AJNR Am J Neuroradiol. 2009 Mar;30(3):552-8. doi: 10.3174/ajnr.A1377. Epub 2008 Dec 4.


Amplifying small amounts of tumor DNA allows detection of DNA copy number abberations with array-CGH.

Prestegarden L, Misra A, Ware ML, Yeh RF, Bjerkvig R, Feuerstein BG.

Biotechniques. 2008 Jun;44(7):Piii-Pvi. doi: 10.2144/000112760.


Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A.

Oncogene. 2008 Jan 17;27(4):441-9. Epub 2007 Jul 16.


Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.

Camacho-Vanegas O, Narla G, Teixeira MS, DiFeo A, Misra A, Singh G, Chan AM, Friedman SL, Feuerstein BG, Martignetti JA.

Int J Cancer. 2007 Sep 15;121(6):1390-5.


Contribution of Notch signaling activation to human glioblastoma multiforme.

Kanamori M, Kawaguchi T, Nigro JM, Feuerstein BG, Berger MS, Miele L, Pieper RO.

J Neurosurg. 2007 Mar;106(3):417-27.


Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma.

Soroceanu L, Kharbanda S, Chen R, Soriano RH, Aldape K, Misra A, Zha J, Forrest WF, Nigro JM, Modrusan Z, Feuerstein BG, Phillips HS.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3466-71. Epub 2007 Feb 20.


Genetic aberrations in gliomatosis cerebri.

Ware ML, Hirose Y, Scheithauer BW, Yeh RF, Mayo MC, Smith JS, Chang S, Cha S, Tihan T, Feuerstein BG.

Neurosurgery. 2007 Jan;60(1):150-8; discussion 158.


Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16466-71. Epub 2006 Oct 20.


A genetic strategy to overcome the senescence of primary meningioma cell cultures.

Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, Feuerstein BG, Deen DF, McDermott MW, Lal A.

J Neurooncol. 2006 Jun;78(2):113-21. Epub 2006 Mar 23.


Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K.

Cancer Cell. 2006 Mar;9(3):157-73.


Biphasic calcium response of platelet-derived growth factor stimulated glioblastoma cells is a function of cell confluence.

Vereb G, Feuerstein BG, Hyun WC, Fulwyler MJ, Balázs M, Szöllosi J.

Cytometry A. 2005 Oct;67(2):172-9.


Chromosome transfer experiments link regions on chromosome 7 to radiation resistance in human glioblastoma multiforme.

Misra A, Pellarin M, Hu L, Kunwar S, Perhouse M, Lamborn KR, Deen DF, Feuerstein BG.

Genes Chromosomes Cancer. 2006 Jan;45(1):20-30.


Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.

Pan E, Pellarin M, Holmes E, Smirnov I, Misra A, Eberhart CG, Burger PC, Biegel JA, Feuerstein BG.

Clin Cancer Res. 2005 Jul 1;11(13):4733-40.


Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines.

Law ME, Templeton KL, Kitange G, Smith J, Misra A, Feuerstein BG, Jenkins RB.

Cancer Genet Cytogenet. 2005 Jul 1;160(1):1-14.


Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma.

Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, Lamborn KR, Pinkel D, Albertson DG, Feuerstein BG.

Clin Cancer Res. 2005 Apr 15;11(8):2907-18.


Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD.

Cancer Res. 2005 Mar 1;65(5):1678-86.


Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.

Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB.

Genes Chromosomes Cancer. 2005 Jan;42(1):68-77.


A complex rearrangement of chromosome 7 in human astrocytoma.

Misra A, Pellarin M, Shapiro JR, Feuerstein BG.

Cancer Genet Cytogenet. 2004 Jun;151(2):162-70.


Grade II astrocytomas are subgrouped by chromosome aberrations.

Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, Feuerstein BG.

Cancer Genet Cytogenet. 2003 Apr 1;142(1):1-7.


Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.

Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD.

Cancer Res. 2002 Nov 1;62(21):6205-10.


Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors.

Zardo G, Tiirikainen MI, Hong C, Misra A, Feuerstein BG, Volik S, Collins CC, Lamborn KR, Bollen A, Pinkel D, Albertson DG, Costello JF.

Nat Genet. 2002 Nov;32(3):453-8. Epub 2002 Sep 30.


Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival.

Kunwar S, Mohapatra G, Bollen A, Lamborn KR, Prados M, Feuerstein BG.

Cancer Res. 2001 Oct 15;61(20):7683-8.


Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.

Burger PC, Minn AY, Smith JS, Borell TJ, Jedlicka AE, Huntley BK, Goldthwaite PT, Jenkins RB, Feuerstein BG.

Mod Pathol. 2001 Sep;14(9):842-53.


Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?

Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D.

Med Pediatr Oncol. 2001 Jan;36(1):5-10.


Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.

Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, Feuerstein BG, Speleman F.

Int J Cancer. 2001 Mar 1;91(5):680-6.


Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.

Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG.

Am J Pathol. 2001 Mar;158(3):1137-43.


Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization.

Brat DJ, Hirose Y, Cohen KJ, Feuerstein BG, Burger PC.

Brain Pathol. 2000 Jul;10(3):342-52.


Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.

Perry A, Anderl K, Borell TJ, Kimmel DW, Wang CH, O'Fallon JR, Feuerstein BG, Scheithauer BW, Jenkins RB.

Am J Clin Pathol. 1999 Dec;112(6):801-9.


Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB.

Oncogene. 1999 Jul 15;18(28):4144-52.


Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.

Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, Mohapatra G, Collins VP, Feuerstein BG.

Cancer. 1999 Jul 15;86(2):331-9.


Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome.

Huhn SL, Mohapatra G, Bollen A, Lamborn K, Prados MD, Feuerstein BG.

Clin Cancer Res. 1999 Jun;5(6):1435-43.


Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization.

Metzger AK, Mohapatra G, Minn YA, Bollen AW, Lamborn K, Waldman FM, Wilson CB, Feuerstein BG.

J Neurosurg. 1999 Feb;90(2):306-14.


EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.

Nagy P, Bene L, Balázs M, Hyun WC, Lockett SJ, Chiang NY, Waldman F, Feuerstein BG, Damjanovich S, Szöllosi J.

Cytometry. 1998 Jun 1;32(2):120-31.


Effects of DFMO on glioma cell proliferation, migration and invasion in vitro.

Terzis AJ, Pedersen PH, Feuerstein BG, Arnold H, Bjerkvig R, Deen DF.

J Neurooncol. 1998 Jan;36(2):113-21.


Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade.

Mohapatra G, Bollen AW, Kim DH, Lamborn K, Moore DH, Prados MD, Feuerstein BG.

Genes Chromosomes Cancer. 1998 Mar;21(3):195-206.


Intraoperative discovery of neuroblastoma in an infant with pulmonary atresia.

McElhinney DB, Reddy VM, Feuerstein BG, Marx GR, Hanley FL.

Ann Thorac Surg. 1997 Dec;64(6):1827-9. Review.


Supplemental Content

Loading ...
Support Center